Anargyros Xenocostas

Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells

Eleftherios Sachlos, Ruth M. Risueño, Sarah Laronde et al. · Cell · 2012 · 452 citations · Full text

Drug Targeting, Medicine, Stem Cell Toxicology +9

Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation

Jennifer J. Trowbridge, Anargyros Xenocostas, Randall T. Moon et al. · Nature Medicine · 2005 · 242 citations

Embryonic Stem Cell, Developmental Biology, Medicine +11

Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche

Allison L. Boyd, Jennifer Reid, Kyle R. Salci et al. · Nature Cell Biology · 2017 · 203 citations

Hematological Malignancy, Bone Marrow Failure, Malignant Blood Disorder +8

Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence

Allison L. Boyd, Lili Aslostovar, Jennifer Reid et al. · Cancer Cell · 2018 · 168 citations · Full text

Hematological Malignancy, Medicine, Transient Vulnerability +9

Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity

Benjamin J. Capoccia, Debra L. Robson, Krysta Levac et al. · Blood · 2009 · 152 citations · Full text